Dr. Chan is a world leader in nanomedicine. Starting with his 1998 Science paper on nano-bioconjugates, he now leads a lab dedicated to characterizing nanoparticle performance in vivo. Warren started Luna with Kyryl to open up his unparalleled expertise in nano to the world, provide custom nanoparticle solutions, and help push the field of nanomedicines forward.

In addition to directing the scientific development of Luna’s technologies, he serves as Canada Research Chair in Nanobioengineering, Director of the Institute of Biomedical Engineering, Editor of the top chemistry ACS Nano journal, and is a Founding member of the Nanomedicine Fabrication Center.

Warren also took an active role in a number of technology translation business ventures in the past. As the company CSO, Warren applies his scientific and technology translation expertise to guide the strategic direction of Luna Diagnostics scientific technology development.

• 

  FOUNDER, CSO in Luna Diagnostics

  Personalized medicine starts with personalized diagnostics.